1-205241802-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014858.4(TMCC2):āc.505A>Gā(p.Ser169Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000995 in 1,607,676 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014858.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMCC2 | NM_014858.4 | c.505A>G | p.Ser169Gly | missense_variant | 2/5 | ENST00000358024.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMCC2 | ENST00000358024.8 | c.505A>G | p.Ser169Gly | missense_variant | 2/5 | 1 | NM_014858.4 | P3 | |
TMCC2 | ENST00000545499.5 | c.271A>G | p.Ser91Gly | missense_variant | 2/5 | 2 | A1 | ||
TMCC2 | ENST00000495538.5 | n.736A>G | non_coding_transcript_exon_variant | 2/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000437 AC: 1AN: 229070Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 126272
GnomAD4 exome AF: 0.00000893 AC: 13AN: 1455484Hom.: 0 Cov.: 31 AF XY: 0.00000967 AC XY: 7AN XY: 723718
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 21, 2024 | The c.505A>G (p.S169G) alteration is located in exon 2 (coding exon 2) of the TMCC2 gene. This alteration results from a A to G substitution at nucleotide position 505, causing the serine (S) at amino acid position 169 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at